IN VITRO MUCOLYTIC ACTIVITY DETERMINATION OF N-ACETYL CYSTEINE EFFERVESCENT TABLET USING SUSPENDED LEVEL VISCOMETER
DOI:
https://doi.org/10.22159/ijap.2023v15i5.48069Keywords:
Mucolytic activity, NAC, ViscosityAbstract
Objective: The objective of the present study was to determine the in vitro mucolytic activity of N-Acetyl Cysteine (NAC) effervescent tablet using egg white solution and suspended level viscometer.
Methods: Egg white has similar physicochemical characteristics with airway mucus, thus in vitro mucolytic activity of NAC effervescent tablets was assessed using an egg white solution and a suspended level viscometer. This was also compared with API and marketed effervescent tablets. Outcomes were statistically analysed using a single-factor ANOVA and a paired t-test.
Results: The results show, in all three cases, i.e., API, Test tablet, and Commercial tablet, viscosity reduced linearly as the concentration was raised from 10 to 60 mg/10 ml having R2 values 0.9973, 0.9909, 0.9953 respectively. When compared to the negative control solution, viscosity rapidly decreased, which amounted to 71.10 %, 73.03 % and 84.63 % of API, Test tablet and Commercial tablet, respectively. The p values of single factor ANOVA and paired t-test were found to be very less than 0.05 in all cases.
Conclusion: NAC effervescent tablet's in vitro mucolytic activity was successfully assessed; results suggested that linearly decreases in viscosity as the concentration of NAC increases and statistical analysis shows significant differences in values.
Downloads
References
Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61(2):75-85. doi: 10.1016/j.addr.2008.09.008, PMID 19135107.
Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010 Dec 2;363(23):2233-47. doi: 10.1056/NEJMra0910061, PMID 21121836.
Sigurdsson HH, Kirch J, Lehr CM. Mucus as a barrier to lipophilic drugs. Int J Pharm. 2013;453(1):56-64. doi: 10.1016/j.ijpharm.2013.05.040, PMID 23727593.
Murgia X, Pawelzyk P, Schaefer UF, Wagner C, Willenbacher N, Lehr CM. Size-limited penetration of nanoparticles into porcine respiratory mucus after aerosol deposition. Biomacromolecules. 2016 Apr 11;17(4):1536-42. doi: 10.1021/acs.biomac.6b00164, PMID 26957140.
Sadowska AM. N-acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2012;6(3):127-35. doi: 10.1177/1753465812437563, PMID 22361928.
McNiff E, Clemente E, Fung HL. In vitro comparison of the mucolytic activity of sodium metabisulfite, n-acetylcysteine and dithiothreitol. Drug Dev Commun. 1974;1(6):507-16. doi: 10.3109/03639047409082341.
King M, Rubin BK. Pharmacological approaches to discovery and development of new mucolytic agents. Adv Drug Deliv Rev. 2002;54(11):1475-90. doi: 10.1016/s0169-409x(02)00156-4, PMID 12458156.
Sheffner AL. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, n-acetyl-l-cysteine. Ann N Y Acad Sci. 1963;106(2):298-310. doi: 10.1111/j.1749-6632.1963.tb16647.x.
Hirsch SR, Viernes PF, Kory RC. The expectorant effect of glyceryl guaiacolate in patients with chronic bronchitis. A controlled in vitro and in vivo study. Chest. 1973;63(1):9-14. doi: 10.1378/chest.63.1.9, PMID 4567445.
Covert WM, Westin SN, Soliman PT, Langley GD. The role of mucoregulatory agents after continence-preserving urinary diversion surgery. Am J Health Syst Pharm. 2012 Mar 15;69(6):483-6. doi: 10.2146/ajhp110212, PMID 22382478.
Fernandes BS, Dean OM, Dodd S, Malhi GS, Berk M. N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. J Clin Psychiatry. 2016 Apr 27;77(4):e457-66. doi: 10.4088/JCP.15r09984, PMID 27137430.
Deepmala SJ, Slattery J, Kumar N, Delhey L, Berk M, Dean O. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015, PMID 25957927.
Dludla PV, Mazibuko Mbeje SE, Nyambuya TM, Mxinwa V, Tiano L, Marcheggiani F. The beneficial effects of N-acetyl cysteine (NAC) against obesity associated complications: a systematic review of pre-clinical studies. Pharmacol Res. 2019 Aug 1;146:104332. doi: 10.1016/j.phrs.2019.104332, PMID 31254666.
Fowdar K, Chen H, He Z, Zhang J, Zhong X, Zhang J. The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: a meta-analysis and systematic review. Heart Lung. 2017 Mar 1;46(2):120-8. doi: 10.1016/j.hrtlng.2016.12.004, PMID 28109565.
Shi Z, Puyo CA. N-acetylcysteine to combat Covid-19: an evidence review. Ther Clin Risk Manag. 2020;16:1047-55. doi: 10.2147/TCRM.S273700, PMID 33177829.
Ibrahim H, Perl A, Smith D, Lewis T, Kon Z, Goldenberg R. Therapeutic blockade of inflammation in severe Covid-19 infection with intravenous N-acetylcysteine. Clin Immunol. 2020 Oct 1;219. doi: 10.1016/j.clim.2020.108544.
Devi N, Boya C, Chhabra M, Bansal D. N-acetyl-cysteine as adjuvant therapy in female infertility: a systematic review and meta-analysis. J Basic Clin Physiol Pharmacol. 2020 Sep 1;32(5):899-910. doi: 10.1515/jbcpp-2020-0107, PMID 34592079.
Rossignol DA. The use of N-acetylcysteine as a chelator for metal toxicity. The Ther Use N-Acetylcysteine (Nac) Med. 2018 Nov 1:169-79. doi: 10.1007/978-981-10-5311-5_10.
Ridhalaksani R, Nazar K, Djauharie NK, Meidyawati R, Npa DA. The antibacterial potential of N-acetylcysteine as an endodontic irrigant on the clinical isolates of the Enterococcus faecalis biofilm. Int J Appl Pharm. 2017 Dec 1;9Special Issue 2:17-9.
Deepika A, Minu S, Singala Surinder K. The role of natural antioxidants as a potential therapeutic agent in nephrolithiasis. Asian J Pharm Clin Res. 2013;6(3):48-53.
Schwalfenberg GK. N-acetylcysteine: a review of clinical usefulness (an old drug with new tricks). J Nutr Metab. 2021;2021:9949453. doi: 10.1155/2021/9949453, PMID 34221501.
Acetylcysteine | C5H9NO3S-PubChem. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/acetylcysteine. [Last accessed on 12 Mar 2023]
Acetylcysteine: uses, interactions, mechanism of action. Drugbank Online. 2003.
Tenorio MCDS, Graciliano NG, Moura FA, de Oliveira ACM, Goulart MOF. N-acetylcysteine (Nac): impacts on human health. Antioxidants (Basel). 2021 Jun 1;10(6):01-34. doi: 10.3390/antiox10060967, PMID 34208683.
Sevier CS, Kaiser CA. Formation and transfer of disulphide bonds in living cells. Nat Rev Mol Cell Biol. 2002;3(11):836-47. doi: 10.1038/nrm954, PMID 12415301.
Vukosavljevic B, Murgia X, Schwarzkopf K, Schaefer UF, Lehr CM, Windbergs M. Tracing molecular and structural changes upon mucolysis with N-acetyl cysteine in human airway mucus. Int J Pharm. 2017 Nov 30;533(2):373-6. doi: 10.1016/j.ijpharm.2017.07.022, PMID 28705614.
Martin R, Litt M, Marriott C. The effect of mucolytic agents on the rheologic and transport properties of canine tracheal mucus. Am Rev Respir Dis. 1980;121(3):495-500. doi: 10.1164/arrd.1980.121.3.495. PMID 6968166.
Davis SS, Scobie S, Inglis A. The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus. Biorheology. 1975;12(3-4):225-32. doi: 10.3233/bir-1975-123-415, PMID 1125.
Legros J, Jan S, Bonnassie S, Gautier M, Croguennec T, Pezennec S. The role of ovotransferrin in egg-white antimicrobial activity: a review. Foods. 2021 Apr 1;10(4):1-21. doi: 10.3390/foods10040823, PMID 33920211.
Alvarado A. Bronchial mucus: basic research and clinical application. Clin Res Trials. 2020;6(5):1-9. doi: 10.15761/CRT.1000316.
Deswati DA, Dhina MA, Mubaroq SR. Mucolytic activity test of shallot extract (Allium ascalonicum L) by in vitro. IOP Conf Ser: Mater Sci Eng. 2018 Jan 25;288(1):1-5. doi: 10.1088/1757-899X/288/1/012141.
Fitria V, Harun N, Gartika L, Kaharto NR, Anwar Hidayat RK, Nandini L. Phytochemical screening and test of mucolytic activity of Nira Stem Sente (Allocasia macrorrhizos) by in vitro. J Phys: Conf Ser. 2019 Aug 30;1179(1):1-6. doi: 10.1088/1742-6596/1179/1/012164.
Kumbar V, Strnkova J, Nedomova S, Buchar J. Fluid dynamics of liquid egg products. J Biol Phys. 2015 Jun 8;41(3):303-11. doi: 10.1007/s10867-015-9380-5, PMID 25761859.
Tadashi Fujita MOTI. Cysteine derivatives US4305958A. United States Patent; 1981. Available from: https://patents.google.com/patent/US4305958A/jp. [Last accessed on 13 Mar 2023]
Viscosity. In: Indian pharmacopoeia. Indian Pharmacopoeia Commission, Indian Pharmacopoeia Laboratory, Govt of India, Ministry of Health and Family Welfare; 2018. p. 252-3.
Published
How to Cite
Issue
Section
Copyright (c) 2023 NANGUDE SATISH, RAVINDRA KAMBLE, VANHERE KAJAL
This work is licensed under a Creative Commons Attribution 4.0 International License.
